How can I differentiate tension‑type headache from migraine and what are the appropriate acute and preventive treatments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Tension-Type Headache from Migraine

Clinical Distinction

Migraine presents with unilateral, pulsating pain of moderate-to-severe intensity that worsens with routine physical activity and is accompanied by nausea and/or photophobia and phonophobia, while tension-type headache presents with bilateral, mild-to-moderate pressing or tightening pain that is not aggravated by routine activity and lacks migraine-associated symptoms. 1

Key Diagnostic Features

Migraine characteristics:

  • Unilateral location (though can be bilateral) 1
  • Pulsating quality 1
  • Moderate-to-severe intensity 1
  • Aggravated by routine physical activity 1
  • Associated with nausea/vomiting 2
  • Photophobia and phonophobia present 2
  • May include visual aura or other sensory changes 2

Tension-type headache characteristics:

  • Bilateral location 1
  • Pressing or tightening (non-pulsating) quality 1
  • Mild-to-moderate intensity 1
  • NOT worsened by routine physical activity 1
  • Lacks nausea, photophobia, and phonophobia 1

Important Diagnostic Caveats

Patients commonly have both conditions as separate disorders—not a "mixed" headache. The International Classification of Headache Disorders does not recognize a mixed migraine-tension type category; each should be diagnosed independently when both are present. 1 This is a critical pitfall: clinicians often incorrectly label overlapping symptoms as "mixed headache" when the patient actually experiences two distinct primary headache disorders. 3

Distinguishing between chronic forms can be particularly challenging, as symptom overlap increases when both conditions become chronic. 4 When diagnostic uncertainty exists between the two, it is reasonable to err on the side of migraine because misdiagnosing migraine as tension-type headache may preclude patients from receiving appropriate migraine-specific treatment. 5


Acute Treatment

For Migraine

NSAIDs are first-line treatment for all migraine attacks, including severe attacks that have previously responded to NSAIDs. 3

First-line acute therapy:

  • Ibuprofen 400-800 mg at headache onset 2
  • Naproxen sodium 500-825 mg 2
  • Aspirin 1000 mg 3
  • Combination of acetaminophen + aspirin + caffeine 3, 2
  • Acetaminophen alone is ineffective for migraine 3, 2

Triptans for moderate-to-severe migraine:

  • Oral triptans: sumatriptan, rizatriptan, naratriptan, zolmitriptan 3
  • Subcutaneous sumatriptan for very rapid onset 3
  • Intranasal sumatriptan for patients with nausea/vomiting 3
  • Add a triptan to an NSAID if NSAIDs alone are inadequate 6
  • Contraindicated in patients with cardiac risk factors, basilar or hemiplegic migraine, or uncontrolled hypertension 3

Intranasal dihydroergotamine (DHE) has good evidence as monotherapy for acute migraine. 3

For Tension-Type Headache

First-line acute therapy:

  • Ibuprofen 400 mg at headache onset 2
  • Acetaminophen 1000 mg 2
  • Acetaminophen 500-650 mg is inadequate and should be avoided 2

Preventive Treatment

Indications for Preventive Therapy

Initiate preventive therapy if:

  • Headaches occur ≥2 times per month with disability lasting ≥3 days per month 6
  • Using acute medications more than 2 days per week 2, 6
  • Contraindications to or failure of multiple acute treatments 6

For Migraine

First-line preventive options:

  • Propranolol 80-240 mg/day: Start low and titrate slowly until clinical benefit or side effects limit further increases 6
  • Beta-blockers (propranolol or metoprolol) particularly if no contraindications like asthma 2
  • Tricyclic antidepressants 7
  • Antiepileptics 7
  • Botulinum toxin for chronic migraine 7

For Tension-Type Headache (Chronic: ≥15 days/month)

Amitriptyline 50-100 mg daily is the only drug with consistent evidence for reducing monthly headache days in chronic tension-type headache. 2

Amitriptyline dosing strategy:

  • Initiate 10-25 mg at bedtime 1
  • Titrate gradually over weeks to months to target of 30-150 mg/day 1
  • Maintain therapeutic dose for 2-3 months before deeming trial unsuccessful 1
  • Monitor for anticholinergic effects (dry mouth, constipation, urinary retention), especially in older adults and those with cardiac comorbidities 2
  • Be aware of overdose potential and weight gain 2

For patients with both migraine and tension-type headache features, amitriptyline is the preferred preventive medication. 1

OnabotulinumtoxinA is NOT recommended for chronic tension-type headache due to lack of efficacy in pooled data from 12 randomized controlled trials. 2


Special Populations

Pregnancy

Acute treatment:

  • Acetaminophen 1000 mg is first-line for both migraine and tension-type headache 1
  • NSAIDs (ibuprofen 400 mg) safe in first and second trimesters but must be avoided in third trimester due to risk of premature ductus arteriosus closure 1
  • Triptans generally contraindicated unless benefit clearly outweighs risk 1
  • Ergot alkaloids contraindicated throughout pregnancy 1

Preventive treatment:

  • Amitriptyline is preferred for pregnant patients with both migraine and tension-type headache features 1
  • Valproate should be avoided due to teratogenic potential 1

Adolescent Females

  • Assess relationship between headaches and menstrual cycle, as hormonal fluctuations commonly trigger migraine 2
  • Short-term prophylaxis with NSAIDs starting 2-3 days before expected menses can be considered for menstrual migraine 2

Red Flags Requiring Immediate Neuroimaging

Obtain MRI or CT immediately if:

  • Sudden "thunderclap" onset 6
  • Headache worsens with Valsalva maneuver or awakens patient from sleep 2, 6
  • Progressive worsening pattern 2
  • Abnormal neurologic examination 2, 6
  • Fever or unexplained systemic symptoms 6
  • New onset in patient over age 50 6
  • Rapidly increasing frequency or severity 6

Critical Pitfall: Medication Overuse Headache

Before escalating therapy for treatment-resistant headache, assess for medication overuse headache: regular use of acute medications on ≥10 days/month for triptans or ≥10 days/month for any combination of acute medications for ≥3 months. 6 This is a common cause of treatment failure and must be addressed before adding preventive therapy.

References

Guideline

Guidelines for Managing Migraine and Tension‑Type Headache in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation and Management of Headaches in Adolescent Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Migraine and Tension-Type Headache: Diagnosis and Treatment.

The Medical clinics of North America, 2019

Guideline

Treatment for Headache Unresponsive to Steroids or OTC Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Migraine and Tension-Type Headache.

Seminars in neurology, 2018

Related Questions

What is the difference between migraine (migraña) and tension headache (cefalea por tensión)?
How do you differentiate between tension headaches and migraine headaches?
What is the difference between tension headaches and migraines in terms of diagnosis and treatment?
What is the difference between a tension headache and a migraine?
What are the guidelines for managing migraines and tension-type headaches?
In a premenopausal woman who received a 3.75 mg leuprolide depot on cycle day 21 and presents on day 3 of menses with bilateral simple ovarian cysts measuring approximately 21 cm total, what are the possible causes and how should this be managed?
What does specialist (maternal‑fetal medicine) monitoring involve, and is it indicated for a pregnant woman with two moderate risk factors for preeclampsia (e.g., nulliparity plus family history of severe preeclampsia or BMI ≥ 35 kg/m²), and does pregnancy‑associated hypertension count as a risk factor that triggers this monitoring?
What are the causes of elevated serum folate?
What are the safest first‑line antidepressants for a patient with an autoimmune disease, considering drug interactions and impact on immune function?
In a patient with a permanent pacemaker who is started on nebivolol (beta‑blocker) and donepezil (acetylcholinesterase inhibitor), should we continue to monitor heart rate and pacemaker function?
In a 34‑year‑old woman with resolved transient pruritic ocular symptoms and a serum albumin of 52 g/L on liver function testing, what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.